HeartSciences Inc. (HSCS) - Form 8-K Summary
Business Context and Reporting Period
HeartSciences Inc., an emerging growth company incorporated in Texas, filed this Current Report on January 13, 2026. The filing discloses the entry into a material definitive agreement involving the issuance of debt securities to an institutional investor.
Key Financial Metrics and Transaction Details
The Company entered into a Note Purchase Agreement with Streeterville Capital, LLC. Key terms include:
- Principal Amount: $3,605,000
- Gross Proceeds: $3,000,000 (after deducting a $600,000 Original Issue Discount and $5,000 in transaction expense reimbursements)
- Interest Rate: 12% per annum
- Maturity: 18 months from issuance
- Repayment Terms: Investor may require monthly redemptions up to $405,000 starting six months after issuance.
- Default Penalty: Interest rate increases to the lesser of 18% or the maximum permitted by law upon an event of default.
The filing does not provide current revenue, profit, cash flow, or existing debt levels outside of this new transaction.
Material Changes and Covenants
This transaction represents a new direct financial obligation. Material conditions include:
- Automatic Increase Clause: If the outstanding balance is not reduced by at least $1,250,000 by the 12-month anniversary, the balance automatically increases by 5%.
- Prepayment: The Company may prepay all or any portion of the Note at any time.
- Covenants: The agreement includes customary restrictive covenants and events of default, including restrictions on fundamental transactions (mergers, consolidations) without investor consent.
Outlook, Risks, and Contingencies
Management commentary is limited to the terms of the agreement. Key risks identified in the filing include:
- Liquidity Risk: The requirement to potentially redeem up to $405,000 monthly starting in July 2026.
- Default Risk: Failure to meet payment obligations or covenants triggers an automatic increase in the interest rate and immediate due date of the outstanding balance.
- Balance Sheet Impact: The 5% automatic increase in principal if specific reduction targets are not met within 12 months.
Investor Verification Checklist
- Verify the Company's current cash position to assess ability to meet the $405,000 monthly redemption requirement starting six months post-issuance.
- Review the full text of the Note Purchase Agreement (Exhibit 10.1) for specific restrictive covenants that may limit operational flexibility.
- Confirm the Company's strategy for reducing the principal balance by $1,250,000 within 12 months to avoid the 5% automatic balance increase.
- Check subsequent filings for any updates on the use of the $3,000,000 gross proceeds.